Jiangli Zhou
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jiangli Zhou has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Gaoyuan Wang
Research Centre of Basic Integrative Medicine, School of Basic Medical Science, Guangzhou University of Chinese Medicine, Guangzhou 510006, China
1 shared publication - Qian Wang
Research Centre of Basic Integrative Medicine, School of Basic Medical Science, Guangzhou University of Chinese Medicine, Guangzhou 510006, China
1 shared publication - Quan Wen
Research Centre of Basic Integrative Medicine, School of Basic Medical Science, Guangzhou University of Chinese Medicine, Guangzhou 510006, China
1 shared publication - Shi Lin
Research Centre of Basic Integrative Medicine, School of Basic Medical Science, Guangzhou University of Chinese Medicine, Guangzhou 510006, China
1 shared publication - Xiaoqin Shao
Research Centre of Basic Integrative Medicine, School of Basic Medical Science, Guangzhou University of Chinese Medicine, Guangzhou 510006, China
1 shared publication - Yating Song
Research Centre of Basic Integrative Medicine, School of Basic Medical Science, Guangzhou University of Chinese Medicine, Guangzhou 510006, China
1 shared publication
Latest Publications
- Open Access
- 17 October 2026
- Published by MDPI AG in Current Issues in Molecular Biology
- Vol. 48 (10) , 1075
The Construction and Validation of a Machine Learning Model for Major Depressive Disorder Based on Astrocytes and Mitochondrial Dynamics
Background: Astrocytes play an important role in depression. However, their specific mechanisms, especially their subcellular mechanisms, remain unclear. Objective: We aimed to identify key genes associated with mitochondrial dynamics and astrocytes in Major Depressive Disorder (MDD), construct a diagnostic prediction model, and elucidate their regulatory mechanisms in neuroinflammation. Methods: Depression-related transcriptome datasets were retrieved from the GEO database. Overlapping differentially expressed genes between mitochondrial dynamics-related and astrocytes-associated genes were screened, followed by functional enrichment analysis. Machine learning algorithms were employed to establish a diagnostic model and identify hub genes. An LPS-induced mouse depression model was established, and depressive-like phenotypes were assessed through behavioral tests. Hub gene expression was validated by using quantitative real-time PCR and Western blotting. Results: A machine learning model with favorable diagnostic performance was constructed. LPS markedly upregulated hexokinase 2 (HK2) and ribosomal protein S7 (RPS7) expression in the prefrontal cortex and hippocampus, suggesting that glycolytic metabolism and ribosomal function contribute to LPS-induced neuropathological changes. Conclusions: HK2 and RPS7 were identified and validated as crucial hub genes responsive to neuroinflammation. The combined action of mitochondrial dynamics and astrocyte metabolic abnormalities may play a key role in depression’s pathogenesis, providing novel candidate biomarkers and theoretical support for the molecular diagnosis of MDD and anti-inflammatory targeted therapy.
- 17 October 2026
- Published by MDPI AG in Current Issues in Molecular Biology
- Vol. 48 (10) , 1075
Open AccessThe Construction and Validation of a Machine Learning Model for Major Depressive Disorder Based on Astrocytes and Mitochondrial Dynamics
Background: Astrocytes play an important role in depression. However, their specific mechanisms, especially their subcellular mechanisms, remain unclear. Objective: We aimed to identify key genes associated with mitochondrial dynamics and astrocytes in Major Depressive Disorder (MDD), construct a diagnostic prediction model, and elucidate their regulatory mechanisms in neuroinflammation. Methods: Depression-related transcriptome datasets were retrieved from the GEO database. Overlapping differentially expressed genes between mitochondrial dynamics-related and astrocytes-associated genes were screened, followed by functional enrichment analysis. Machine learning algorithms were employed to establish a diagnostic model and identify hub genes. An LPS-induced mouse depression model was established, and depressive-like phenotypes were assessed through behavioral tests. Hub gene expression was validated by using quantitative real-time PCR and Western blotting. Results: A machine learning model with favorable diagnostic performance was constructed. LPS markedly upregulated hexokinase 2 (HK2) and ribosomal protein S7 (RPS7) expression in the prefrontal cortex and hippocampus, suggesting that glycolytic metabolism and ribosomal function contribute to LPS-induced neuropathological changes. Conclusions: HK2 and RPS7 were identified and validated as crucial hub genes responsive to neuroinflammation. The combined action of mitochondrial dynamics and astrocyte metabolic abnormalities may play a key role in depression’s pathogenesis, providing novel candidate biomarkers and theoretical support for the molecular diagnosis of MDD and anti-inflammatory targeted therapy.